Hwei‐Fang Tien

24.2k total citations
299 papers, 7.9k citations indexed

About

Hwei‐Fang Tien is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Hwei‐Fang Tien has authored 299 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Hematology, 92 papers in Molecular Biology and 86 papers in Genetics. Recurrent topics in Hwei‐Fang Tien's work include Acute Myeloid Leukemia Research (147 papers), Lymphoma Diagnosis and Treatment (53 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (46 papers). Hwei‐Fang Tien is often cited by papers focused on Acute Myeloid Leukemia Research (147 papers), Lymphoma Diagnosis and Treatment (53 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (46 papers). Hwei‐Fang Tien collaborates with scholars based in Taiwan, United States and United Kingdom. Hwei‐Fang Tien's co-authors include Jih‐Luh Tang, Ming Yao, Wen‐Chien Chou, Woei Tsay, Hsin‐An Hou, Shang‐Yi Huang, Chien‐Yuan Chen, Yee‐Chun Chen, Yao‐Chang Chen and Liang‐In Lin and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hwei‐Fang Tien

285 papers receiving 7.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hwei‐Fang Tien Taiwan 49 3.9k 2.8k 1.7k 1.6k 1.3k 299 7.9k
Bruno Varet France 37 4.1k 1.0× 1.7k 0.6× 2.6k 1.5× 1.4k 0.9× 554 0.4× 145 7.6k
Renato Fanin Italy 42 3.6k 0.9× 1.4k 0.5× 1.4k 0.8× 2.0k 1.2× 665 0.5× 226 6.6k
Howard A. Liebman United States 47 3.4k 0.9× 979 0.3× 996 0.6× 1.0k 0.6× 911 0.7× 157 9.9k
Gösta Gahrton Sweden 52 4.1k 1.1× 2.6k 0.9× 2.3k 1.3× 2.2k 1.4× 898 0.7× 268 8.3k
Jan J. Cornelissen Netherlands 58 7.1k 1.8× 1.9k 0.7× 1.7k 1.0× 3.4k 2.1× 2.6k 2.1× 319 13.0k
Raymond Liang China 52 2.1k 0.5× 1.7k 0.6× 1.2k 0.7× 3.7k 2.2× 3.1k 2.5× 275 10.3k
Jayesh Mehta United States 46 4.9k 1.3× 2.7k 1.0× 1.0k 0.6× 2.8k 1.7× 1.3k 1.0× 226 8.3k
François Dreyfus France 42 4.0k 1.0× 3.0k 1.1× 1.6k 0.9× 1.0k 0.6× 452 0.4× 126 6.2k
Augustin Ferrant Belgium 52 6.5k 1.7× 2.5k 0.9× 2.3k 1.3× 3.1k 1.9× 813 0.6× 225 10.9k
Takanori Teshima Japan 52 5.6k 1.4× 1.8k 0.6× 1.0k 0.6× 2.5k 1.5× 1.1k 0.9× 486 10.6k

Countries citing papers authored by Hwei‐Fang Tien

Since Specialization
Citations

This map shows the geographic impact of Hwei‐Fang Tien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hwei‐Fang Tien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hwei‐Fang Tien more than expected).

Fields of papers citing papers by Hwei‐Fang Tien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hwei‐Fang Tien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hwei‐Fang Tien. The network helps show where Hwei‐Fang Tien may publish in the future.

Co-authorship network of co-authors of Hwei‐Fang Tien

This figure shows the co-authorship network connecting the top 25 collaborators of Hwei‐Fang Tien. A scholar is included among the top collaborators of Hwei‐Fang Tien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hwei‐Fang Tien. Hwei‐Fang Tien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yu‐Wen, Hao-Yang Lin, Chien‐Chin Lin, et al.. (2025). Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring Systems. Hematological Oncology. 43(1). e70040–e70040.
2.
Tsai, Cheng‐Hong, et al.. (2025). Annotation-free deep learning for predicting gene mutations from whole slide images of acute myeloid leukemia. npj Precision Oncology. 9(1). 35–35. 2 indexed citations
3.
Lin, Chien‐Chin, Chia‐Lang Hsu, Chi‐Yuan Yao, et al.. (2024). HOPX as a tumour‐suppressive protein in T‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 206(2). 505–516.
4.
Cheng, Chieh‐Lung, You‐Yu Lin, Chia‐Lang Hsu, et al.. (2024). Unraveling the role of hepatitis B virus DNA integration in B-cell lymphomagenesis. British Journal of Cancer. 131(6). 996–1004. 2 indexed citations
5.
Lin, Chien‐Chin, Cheng‐Hong Tsai, Feng‐Ming Tien, et al.. (2024). Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood Cancer Journal. 14(1). 57–57. 7 indexed citations
6.
Cheng, Chieh‐Lung, Po‐Ting Yeh, Weili Ma, et al.. (2023). Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma. Cancer Medicine. 12(7). 8102–8111. 4 indexed citations
7.
Yao, Chi‐Yuan, Chien‐Chin Lin, Chi‐Ling Chen, et al.. (2022). Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients. SHILAP Revista de lepidopterología. 3(4). 1209–1219. 4 indexed citations
8.
Hou, Hsin‐An, et al.. (2021). Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015. Annals of Hematology. 101(1). 109–118. 1 indexed citations
9.
Wang, Yu‐Fen, Bor‐Sheng Ko, Chi‐Cheng Li, et al.. (2017). An Artificial Intelligence Approach for B Lymphoblastic Leukemia Minimal Residual Disease Detection and Clinical Prognosis Prediction Using Flow Cytometry Data. Blood. 130. 3980–3980. 1 indexed citations
10.
Wei, Tong‐You Wade, Pei‐Yu Wu, Ting‐Jung Wu, et al.. (2016). Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA. Cancer Research. 77(2). 494–508. 45 indexed citations
11.
Chen, Chien‐Yuan, Liang‐In Lin, Jih‐Luh Tang, et al.. (2007). RUNX1 gene mutation in primary myelodysplastic syndrome – the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome. British Journal of Haematology. 139(3). 405–414. 88 indexed citations
12.
Chou, Wen‐Chien, Jih‐Luh Tang, Liang‐In Lin, et al.. (2006). Nucleophosmin Mutations in De novo Acute Myeloid Leukemia: The Age-Dependent Incidences and the Stability during Disease Evolution. Cancer Research. 66(6). 3310–3316. 115 indexed citations
13.
Li, Chi‐Cheng, Hwei‐Fang Tien, Jih‐Luh Tang, et al.. (2004). Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T‐cell or T‐cell lymphoma. Cancer. 100(2). 366–375. 141 indexed citations
14.
Huang, Shang‐Yi, Cheng‐Shyong Chang, Jih‐Luh Tang, et al.. (1998). Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia. British Journal of Haematology. 103(4). 1092–1095. 95 indexed citations
15.
16.
17.
Tien, Hwei‐Fang, C. M. Suchindran, Aaron Lin, et al.. (1994). The National Epidermolysis Bullosa (EB) Registry — Risk of prematurity, frequency of pregnancy complications, and effect of maternal and paternal ages on the development of each of the major EB types. Journal of Investigative Dermatology. 103(6). 846. 1 indexed citations
18.
Fine, JD, Hwei‐Fang Tien, C. M. Suchindran, et al.. (1994). The National Epidermolysis Bullosa Registry — Assessment of interobserver variability by sensitivity and specificity analysis of two major clinical parameters. Journal of Investigative Dermatology. 103(6). 846. 2 indexed citations
19.
Fine, JD, Hwei‐Fang Tien, C. M. Suchindran, et al.. (1994). Classification and regression tree (CART) statistical technique for diagnosis of major types of inherited epidermolysis bullosa (EB). A split sample analysis of the national EB registry dataset. Journal of Investigative Dermatology. 103(6). 846. 2 indexed citations
20.
Tien, Hwei‐Fang, et al.. (1991). A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Varet Breakdown of academic impact, for papers by Renato Fanin Breakdown of academic impact, for papers by Howard A. Liebman Breakdown of academic impact, for papers by Gösta Gahrton Breakdown of academic impact, for papers by Jan J. Cornelissen Breakdown of academic impact, for papers by Raymond Liang Breakdown of academic impact, for papers by Jayesh Mehta Breakdown of academic impact, for papers by François Dreyfus Breakdown of academic impact, for papers by Augustin Ferrant Breakdown of academic impact, for papers by Takanori Teshima
Rankless by CCL
2026